Literature DB >> 30638423

Person-centered risk assessment framework: assessing and managing risk in older adults living with dementia.

Linda Lee1,2, Loretta M Hillier3, Stephanie K Lu1, Sharon Dillon Martin1, Sarah Pritchard1, Jennifer Janzen1, Karen Slonim1.   

Abstract

AIM: This study pilot-tested the person-centered risk assessment framework (PCRAF), a framework for managing risk among persons living with dementia (PLWD) in primary care.
METHODS: Healthcare providers (N = 7) piloting the PCRAF completed a survey, rating their satisfaction with the tool, and an interview to gather their perceptions of the PCRAF. PLWD and care partners (N = 12) completed a survey, rating their satisfaction with safety planning.
RESULTS: Care providers were very satisfied with the tool; however, patient or care partner inability to perceive or understand safety risks was a challenge. Use of the PCRAF was perceived as an opportunity to empower self-management, gather PLWD and care partner perspectives, reduce burden for care partners and increase understanding of potential risks. Patients and care partners were very satisfied with the way in which they were included in the risk discussion.
CONCLUSION: The PCRAF is a promising new tool to reduce risks associated with dementia.

Entities:  

Keywords:  caregiving; dementia; memory clinics; primary care; risk assessment

Year:  2019        PMID: 30638423     DOI: 10.2217/nmt-2018-0031

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  2 in total

1.  Development of a Psychometric Test: A Care Risk Scale for Homebound Older People With Dementia.

Authors:  Xiaoxin Dong; Lingbo Zhao; Xianbo Kong; Ting Xu; Tongda Sun
Journal:  Front Psychol       Date:  2022-05-13

2.  Delaying Transition Into Long-Term Care for Persons Living With Dementia: Multispecialty Interprofessional Team Memory Clinics.

Authors:  Linda Lee; Loretta M Hillier; Tejal Patel; Frank Molnar; Michael Borrie; Jo-Anne Clarke
Journal:  J Am Med Dir Assoc       Date:  2020-08-20       Impact factor: 4.669

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.